EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for mouse hematopoietic cells serum containing'
-
NeuroCult™ Proliferation Media Learn about standardized, serum-free NeuroCult™ Proliferation Media for expansion of NSPCs in neurosphere and adherent monolayer cultures -
How to Optimize Your T Cell Therapy Workflow—Without the Use of Serum or Feeder Cells In this talk, Dr. Dominika Nackiewicz introduces how STEMCELL Technologies can help optimize your T cell cultures with robust, high-performance products and expert support. You will learn how to generate high yields of functional T cells for cell therapy development and manufacturing using the new GMP ImmunoCult™ medium and activators. She will also discuss efficient gene editing strategies using the new CellPore™ Transfection System and solutions for T cell generation from pluripotent stem cells or hematopoietic stem and progenitor cells.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts. -
Advances in Point-of-Care Cell Engineering—What Are You Feeding Your CAR T Cells? In this webinar, Dr. Julian J. Lum discusses key factors to consider when choosing metabolic assays and how they can be used to assess cell function. Additionally, he discusses the metabolic characteristics of different commercially available cell culture media formulations as well as the importance of assessing the array of media products and their impact on metabolism.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts. -
Optimization of ALDEFLUOR™ Protocol Learn how STEMCELL Technologies' scientists doubled the signal strength in mammary epithelial cells with a few simple protocol modifications using ALDEFLUOR™ to detect Aldehyde Dehydrogenase bright (ALDHbr) cells -
How to Detect and Isolate Normal and Cancer Stem Cells Based on ALDH Activity with ALDEFLUOR™ An innovative, antibody-free system to rapidly identify stem and progenitor cells of several tissue types, including a variety of cancer stem cells -
Non-Viral CRISPR Knock-In Anti-B7-H3 CAR-T Cells Are Amenable for Treatment of Subtypes of Small Cell Lung Cancer In this webinar, Scientist Vimal Keerthi discusses his work on identifying CD276 (B7-H3) overexpression in primary human SCLC and developing a non-viral CRISPR-Cas9 knock-in (CKI) based platform against B7-H3 to manufacture CAR T cells for the treatment of SCLC. He demonstrates the feasibility of this CAR T manufacturing platform and how this provides a blueprint for immediate clinical translation, overcoming the bottleneck of viral vector production.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts. -
CAR T Cell Manufacturing Workflow: Isolation, Activation and Expansion Learn about human T cell isolation, activation, and expansion workflow for cell therapy -
How ALDEFLUOR™ ALDH Assay Kit Detects Normal and Cancer Progenitor Cells How the ALDEFLUOR™ assay works to detect aldehyde dehydrogenase (ALDH)-bright cells
